In Wired: Overview of advances in biochips, chips that mimic the activity of the body, used for the development and testing of drugs. I note the term new to me: Organoids. We participated in several examinations of these methods.
" ... But if they come to fruition, organoids could lead to even larger opportunities, beyond the speed of drug research and the price of medications. Today, much pre-clinical work is done in animals and doesn’t always yield results that mimic how human systems work. “The knowledge gaps we face in biomedical research are enormous. We just don’t know all that much about what causes diseases,” says Bernard Munos, the founder of the Innothink Center for Research in Biomedical Innovation who also sits on the Cures Acceleration Network board. “We’re really throwing darts.”But if they come to fruition, organoids could lead to even larger opportunities, beyond the speed of drug research and the price of medications. Today, much pre-clinical work is done in animals and doesn’t always yield results that mimic how human systems work. “The knowledge gaps we face in biomedical research are enormous. We just don’t know all that much about what causes diseases,” says Bernard Munos, the founder of the Innothink Center for Research in Biomedical Innovation who also sits on the Cures Acceleration Network board. “We’re really throwing darts.” .... "
No comments:
Post a Comment